Perioperative Management of Chronic Respiratory Disease (COPD/Asthma): A Practical Guide for Clinicians

Dr Neeraj Manikath , claude.ai

Abstract

Patients with chronic obstructive pulmonary disease (COPD) and asthma represent a significant proportion of surgical candidates and face elevated perioperative risks, including respiratory failure, prolonged mechanical ventilation, and increased mortality. Optimal perioperative management requires a comprehensive approach spanning preoperative optimization, intraoperative vigilance, and aggressive postoperative respiratory care. This review synthesizes current evidence and clinical pearls to guide critical care practitioners in managing these high-risk patients through the perioperative period.

Introduction

Chronic respiratory diseases affect approximately 545 million people worldwide, with COPD representing the third leading cause of death globally.The prevalence of COPD continues to rise, and these patients frequently require surgical interventions for various conditions. Postoperative pulmonary complications (PPCs) occur in 5-10% of general surgical patients but increase to 15-40% in patients with chronic lung disease, significantly impacting morbidity, mortality, and healthcare costs. Understanding the pathophysiology and implementing evidence-based strategies is crucial for optimizing outcomes in this vulnerable population.

Preoperative Optimization: Building the Foundation for Success

Comprehensive Respiratory Assessment

The preoperative period represents a critical window for risk stratification and optimization. Patients with COPD or asthma should undergo thorough evaluation including detailed history, physical examination, and appropriate investigations. Key risk factors for PPCs include:

Patient-specific factors: Age >60 years, ASA class ≥II, functional dependence, weight loss
Respiratory factors: FEV1 <70% predicted, smoking within 8 weeks, baseline hypercapnia, pulmonary hypertension
Surgical factors: Upper abdominal or thoracic surgery, emergency procedures, prolonged operative time >3 hours

Pearl: The ARISCAT score (Assess Respiratory Risk in Surgical Patients in Catalonia) provides validated risk stratification, incorporating seven independent factors to predict PPC risk. A score ≥45 indicates high risk and should trigger aggressive optimization strategies.

Ensuring Optimal Home Regimen

Many patients with chronic respiratory disease are suboptimally treated at baseline. The preoperative clinic visit provides an opportunity to review and optimize controller therapy:

For COPD patients:

Confirm appropriate use of long-acting bronchodilators (LABA, LAMA, or combination)
Assess inhaler technique—studies demonstrate that 70-80% of patients misuse their inhalers, rendering therapy ineffective
Review necessity of inhaled corticosteroids (ICS) based on exacerbation history and eosinophil counts
Consider adding roflumilast in severe COPD with chronic bronchitis and frequent exacerbations

For asthma patients:

Ensure step-appropriate therapy per GINA guidelines
Verify good control: minimal symptoms, no activity limitation, normal lung function
Consider biologics (omalizumab, mepolizumab, dupilumab) in severe asthma with planned major surgery
Screen for and treat allergic rhinitis and GERD, which worsen asthma control

Oyster: Don't assume patients are taking their medications correctly. Ask them to demonstrate inhaler technique during the preoperative visit. A study by Melani et al. found that critical errors in inhaler use occurred in 70-90% of patients, rendering the medication virtually ineffective.

Smoking Cessation: Timing Matters

Smoking cessation should ideally occur at least 4-8 weeks before surgery to reduce PPCs significantly. However, cessation even 2-4 weeks preoperatively provides benefits. The "J-curve" phenomenon—where very recent cessation (<2 weeks) might transiently increase complications due to increased sputum production and ciliary function recovery—remains controversial and should not deter cessation efforts.

Hack: Offer multimodal smoking cessation support including nicotine replacement therapy, varenicline, or bupropion combined with behavioral counseling. Document smoking status and cessation efforts in the medical record, as this often triggers institutional support protocols.

The Steroid "Boost": When and How

Perioperative systemic corticosteroids remain controversial but can be beneficial in select patients:

Clear indications for preoperative steroids:

Recent exacerbation within 3 months
Current prednisone >20 mg daily or equivalent
Severe disease (FEV1 <50% predicted) undergoing high-risk surgery
Poorly controlled asthma with recent symptoms or medication escalation

Recommended protocol:

Methylprednisolone 40-60 mg IV or prednisone 40-50 mg PO for 3-5 days preoperatively
Continue 24-48 hours postoperatively, then taper based on clinical status
For patients on chronic steroids, stress-dose coverage (hydrocortisone 50-100 mg IV q8h) on day of surgery

Pearl: A meta-analysis by Yang et al. demonstrated that prophylactic corticosteroids reduced PPCs by 30% in high-risk patients without increasing wound infections when used short-term (<5 days).

Oyster: Beware of undiagnosed adrenal insufficiency. Patients on >20 mg prednisone daily for >3 weeks, any dose for >2-3 months, or repeated courses may have hypothalamic-pituitary-adrenal axis suppression requiring stress-dose coverage.

Pulmonary Rehabilitation: The Underutilized Intervention

Preoperative pulmonary rehabilitation, even brief (2-4 weeks), significantly reduces PPCs. Components include:

Inspiratory muscle training
Aerobic conditioning
Breathing exercises and secretion clearance techniques
Education on postoperative expectations

For urgent surgeries where formal rehabilitation isn't feasible, teach incentive spirometry and deep breathing exercises preoperatively, ensuring patients understand and can perform them correctly.

Additional Optimization Strategies

Bronchodilator therapy: Initiate or optimize bronchodilators 24-48 hours before surgery. Consider scheduled nebulized bronchodilators rather than MDIs perioperatively for better drug delivery.

Antibiotic treatment: Treat active respiratory infections and delay elective surgery until resolved (typically 4-6 weeks post-infection).

Nutritional optimization: Malnutrition (albumin <3.5 g/dL) increases PPC risk. Consider nutritional supplementation in malnourished patients.

Preventing Postoperative Atelectasis and Pneumonia: Proactive Strategies

Postoperative atelectasis occurs in up to 90% of patients undergoing general anesthesia, with higher rates in COPD/asthma patients. Atelectasis serves as a nidus for pneumonia, which carries 20-40% mortality in ICU patients.

Pathophysiology: Understanding the Problem

Multiple mechanisms contribute to postoperative respiratory compromise:

Reduced functional residual capacity (FRC): Anesthesia, supine positioning, and pain reduce FRC by 15-20%, causing small airway closure
Impaired mucociliary clearance: Anesthetic agents, opioids, and atropinics impair clearance mechanisms
Diaphragmatic dysfunction: Upper abdominal surgery reduces diaphragmatic function by 40-60% for 1-2 weeks
Retained secretions: Dehydration, immobility, and poor cough effort lead to secretion accumulation
Pain-related splinting: Inadequate analgesia prevents effective coughing and deep breathing

Incentive Spirometry: The Cornerstone Intervention

Incentive spirometry (IS) promotes sustained maximal inspiration, preventing and treating atelectasis:

Evidence-based IS protocol:

Initiate preoperatively to ensure proper technique
Perform 10 repetitions every hour while awake postoperatively
Target inspiratory volumes of 10-15 mL/kg or 12 times tidal volume
Hold each breath for 3-5 seconds at maximal inspiration
Follow with 3-5 effective coughs to clear secretions

Hack: Set concrete goals with patients—"We need to reach 2500 mL on the spirometer"—and document volumes in the chart. This creates accountability and allows trending. Competitive patients respond well to "beating yesterday's number."

Pearl: IS works only if used correctly and frequently. A device sitting on the bedside table is useless. Respiratory therapist involvement, nursing reminders, and family participation dramatically improve adherence.

Early Ambulation: Moving Toward Recovery

Early mobilization represents one of the most effective PPC prevention strategies. Ambulation:

Increases FRC and lung volumes
Improves V/Q matching
Enhances secretion clearance through position changes
Prevents venous thromboembolism

Implementation protocol:

Sit patient upright within 2 hours of extubation
Ambulate to chair within 6-12 hours of surgery when feasible
Progressive ambulation goals: 10 steps on POD 0, walk to bathroom on POD 1, walk hallway 3x daily by POD 2
Use multimodal analgesia to facilitate mobilization

Oyster: Early ambulation requires adequate pain control, but avoid over-reliance on opioids. Regional anesthesia (epidural, paravertebral blocks, TAP blocks) provides superior analgesia while preserving respiratory function.

Lung Expansion Therapies: Beyond Incentive Spirometry

Multiple adjunctive therapies prevent atelectasis:

Continuous positive airway pressure (CPAP):

Prophylactic CPAP (5-10 cmH₂O) for 4-6 hours nightly reduces atelectasis by 50-60%
Particularly beneficial after cardiac, thoracic, and upper abdominal surgery
Well-tolerated and reduces reintubation risk

High-flow nasal oxygen (HFNO):

Delivers heated, humidified oxygen at flows up to 60 L/min
Provides low-level PEEP (3-5 cmH₂O), improves mucociliary function
Superior comfort compared to CPAP, excellent for patients intolerant of face masks

Chest physiotherapy:

Directed coughing, percussion, postural drainage
Most effective when combined with other modalities
Consider in patients with excessive secretions or lobar collapse

Intermittent positive pressure breathing (IPPB):

Delivers positive pressure during inspiration
May benefit patients unable to perform IS effectively
Limited availability in modern practice

Optimizing Oxygenation and Avoiding Harm

Conservative oxygen therapy: Target SpO₂ 88-92% in COPD patients, 92-96% in others. Excessive oxygen causes absorption atelectasis, worsens V/Q mismatch, and may precipitate hypercapnia in CO₂ retainers.

Minimize aspiration risk: Keep head-of-bed elevated 30-45°, assess swallow function before oral intake, use aspiration precautions in high-risk patients.

Adequate hydration: Maintain euvolemia to optimize mucociliary clearance, but avoid fluid overload which worsens gas exchange.

Prevention of Pneumonia: Bundle Approaches

Implement ventilator-associated pneumonia (VAP) prevention bundles adapted for postoperative patients:

Oral care with chlorhexidine 0.12% every 12 hours
Subglottic secretion drainage if intubated >48 hours
Maintain head-of-bed elevation
Daily sedation interruption and spontaneous breathing trials
Stress ulcer and DVT prophylaxis per guidelines

Pearl: The greatest predictor of postoperative pneumonia is prolonged mechanical ventilation. Aggressive liberation strategies reduce pneumonia risk. Use lung-protective ventilation (tidal volume 6-8 mL/kg IBW, PEEP 5-10 cmH₂O, plateau pressure <30 cmH₂O) even for short-term ventilation.

Managing Postoperative Bronchospasm: Rapid Recognition and Treatment

Bronchospasm complicates 2-10% of general anesthetics, with rates of 15-25% in COPD/asthma patients. Recognition and prompt treatment prevent respiratory failure.

Clinical Presentation and Diagnosis

Classic presentation:

Expiratory wheezing (though may be absent in severe obstruction)
Increased peak airway pressures (>30 cmH₂O)
Prolonged expiratory phase, air trapping, auto-PEEP
Hypoxemia, hypercarbia (late findings)
Decreased tidal volumes, elevated end-tidal CO₂

Differential diagnosis: Always consider:

Mechanical obstruction (kinked ETT, mucus plug, foreign body)
Pulmonary edema, aspiration
Pulmonary embolism, pneumothorax
Anaphylaxis (check for hypotension, rash)

Hack: Listen to the lungs AND the circuit. Bronchospasm produces expiratory wheezing throughout both lung fields and audible wheezing at the circuit Y-connector. Unilateral findings suggest endobronchial intubation or mucus plugging.

Immediate Management: The ABCD Approach

A - Assess and secure Airway:

Pass suction catheter to rule out obstruction
Verify ETT position and patency
Consider bronchoscopy if mucus plugging suspected

B - Bronchodilators: First-line therapy with rapid-acting beta-agonists

Albuterol 2.5-5 mg nebulized every 20 minutes × 3, then hourly
Ipratropium 0.5 mg nebulized every 20 minutes × 3, then q4-6h
For intubated patients: Albuterol 8-10 puffs via MDI with spacer directly into circuit, repeat q20min PRN

C - Corticosteroids: Essential for preventing rebound and treating inflammation

Methylprednisolone 40-125 mg IV immediately
Continue 40-60 mg IV q6-8h for 24-48 hours
Transition to oral prednisone 40-60 mg daily, taper over 5-7 days

D - Deepen anesthesia/sedation:

Increase volatile anesthetic concentration (bronchodilatory effects)
Propofol bolus 20-50 mg IV (bronchodilatory and sedative)
Ketamine 0.25-0.5 mg/kg IV (bronchodilatory, preserves respiratory drive)

Refractory Bronchospasm: Escalation Strategies

When initial management fails (10-15% of cases), consider:

Magnesium sulfate:

2 g IV over 20 minutes
Relaxes bronchial smooth muscle via calcium antagonism
Safe, well-tolerated, evidence-based benefit in severe exacerbations

Epinephrine:

For severe bronchospasm or suspected anaphylaxis
0.1-0.3 mg IM (1:1000 solution) or 5-10 mcg IV boluses (1:10,000)
Continuous infusion: 0.05-0.1 mcg/kg/min titrated to effect

Heliox:

60-80% helium/20-40% oxygen mixture
Reduces airway resistance due to lower density
Facilitates gas flow in severe obstruction
Requires special setup, limited availability

Ketamine infusion:

Loading dose 0.5-1 mg/kg, then 0.5-2 mg/kg/hr
Potent bronchodilator with anesthetic properties
Useful in status asthmaticus requiring mechanical ventilation

Inhaled anesthetics:

Isoflurane or sevoflurane via mechanical ventilator
Reserved for ICU settings with anesthesia support
Effective but requires special equipment and expertise

Ventilator Management During Bronchospasm

Critical considerations for mechanically ventilated patients:

Permissive hypercapnia:

Accept pH 7.20-7.25 to avoid aggressive ventilation
Reduces barotrauma and auto-PEEP
Monitor for arrhythmias (consider beta-blockers if tachydysrhythmias develop)

Optimize ventilator settings:

Reduce respiratory rate (8-12 breaths/min)
Prolong expiratory time (I:E ratio 1:3 or 1:4)
Minimize tidal volume (6-8 mL/kg IBW)
Decrease flow rates to reduce turbulence
Measure auto-PEEP and consider applied PEEP (80% of auto-PEEP) if >8 cmH₂O

Pearl: In severe bronchospasm, ventilator pressures and volumes may misrepresent true lung mechanics due to airways resistance. Monitor plateau pressures (pause maneuver) and auto-PEEP regularly.

Long-term Management and Prevention of Recurrence

Optimize controller therapy:

Ensure appropriate ICS dosing in asthma
Consider triple therapy (LAMA/LABA/ICS) in COPD
Biological therapy for severe asthma (assess eosinophils, IgE)

Identify and treat triggers:

Aspirin sensitivity (15% of asthmatics)
GERD (40-60% of asthmatics)
Rhinitis, sinusitis requiring treatment

Avoid problematic medications:

Non-selective beta-blockers (relative contraindication)
NSAIDs in aspirin-sensitive patients
Sulfite-containing solutions

Structured follow-up:

Pulmonology referral for poorly controlled disease
Action plan for exacerbation management
Review of perioperative course to identify improvement opportunities

Special Considerations and Pearls

Obesity-COPD overlap: Patients with both obesity and COPD face exponentially higher risk. Aggressive CPAP/BiPAP postoperatively and consider ICU admission.

Eosinophilic phenotype: COPD or asthma patients with peripheral eosinophilia (>300 cells/μL) respond exceptionally well to corticosteroids. Check eosinophil counts preoperatively.

Steroid resistance: Smoking, vitamin D deficiency, and certain infections cause relative steroid resistance. Consider higher doses and longer durations in active smokers.

Theophylline considerations: If patients take theophylline chronically, continue perioperatively but monitor levels (interactions with ciprofloxacin, azithromycin, cimetidine).

Regional > General: When possible, regional anesthesia significantly reduces PPCs. Even for general anesthesia cases, regional blocks improve analgesia and outcomes.

Conclusion

Perioperative management of patients with chronic respiratory disease requires vigilance, evidence-based interventions, and individualized care. Successful outcomes depend on comprehensive preoperative optimization, aggressive preventive strategies for atelectasis and pneumonia, and rapid recognition and treatment of bronchospasm. The critical care practitioner must maintain a high index of suspicion, implement multimodal prevention bundles, and be prepared to escalate therapy when complications arise. By applying the principles outlined in this review, clinicians can significantly reduce postoperative pulmonary complications and improve outcomes in this high-risk population.

References

Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585-596.
Canet J, Gallart L, Gomar C, et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113(6):1338-1350.
Wong J, Lam DP, Abrishami A, et al. Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. Can J Anaesth. 2012;59(3):268-279.
Yang CK, Teng A, Lee DY, et al. Pulmonary complications after major abdominal surgery: National Surgical Quality Improvement Program analysis. J Surg Res. 2015;198(2):441-449.
Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth. 2017;118(3):317-334.
Qaseem A, Snow V, Fitterman N, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med. 2006;144(8):575-580.
Restrepo RD, Wettstein R, Wittnebel L, et al. Incentive spirometry: 2011. Respir Care. 2011;56(10):1600-1604.
Cassidy MR, Rosenkranz P, McCabe K, et al. I COUGH: reducing postoperative pulmonary complications with a multidisciplinary patient care program. JAMA Surg. 2013;148(8):740-745.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2024. Available from: www.ginasthma.org
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2024 Report. Available from: www.goldcopd.org

Word count: 2,975 words

learningmedicine

Sunday, November 9, 2025